Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
8.00
+0.06 (0.76%)
At close: Jun 11, 2026, 4:00 PM EDT
8.10
+0.10 (1.25%)
After-hours: Jun 11, 2026, 4:57 PM EDT

Ginkgo Bioworks Holdings Revenue

Ginkgo Bioworks Holdings had revenue of $19.47M in the quarter ending March 31, 2026, a decrease of -49.06%. This brings the company's revenue in the last twelve months to $121.84M, down -35.57% year-over-year. In the year 2025, Ginkgo Bioworks Holdings had annual revenue of $170.16M, down -25.06%.

Revenue (ttm)
$121.84M
Revenue Growth
-35.57%
P/S Ratio
3.45
Revenue / Employee
$312,163
Employees
485
Market Cap
522.60M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025170.16M-56.89M-25.06%
Dec 31, 2024227.04M-24.41M-9.71%
Dec 31, 2023251.46M-226.25M-47.36%
Dec 31, 2022477.71M163.87M52.21%
Dec 31, 2021313.84M237.18M309.40%
Dec 31, 202076.66M22.47M41.48%
Dec 31, 201954.18M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
MiMedx Group389.42M
Valneva SE180.25M
Gyre Therapeutics117.05M
XOMA Royalty48.56M
Prime Medicine4.03M
ProKidney889.00K
Altimmune36.00K
Revenue Rankings